Articles

Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma

Department of Clinical Therapeutics, University of Athens School of Medicine, Greece
The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Hôpital Claude-Huriez, Lille, France
Department of Hematology, Erasmus Medical Centre, University Hospital Rotterdam, The Netherlands
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Hematology Department, The Ankara University School of Medicine, Turkey
Centre Régional de Cancérologie Henry Kaplan (CHRU de Tours), and Hôpital Bretonneau, Tours, France
Haematology Department, Western General Hospital, Edinburgh, Scotland, UK
Janssen-Cilag Pharmaceutical SACI, Athens, Greece
Janssen-Cilag, Issy Les Moulineaux, France
Janssen Research & Development, LLC, Raritan, NJ, USA
Janssen-Cilag UK, High Wycombe, England, UK
Janssen Research & Development, Division of Janssen Pharmaceutica NV, Beerse, Belgium
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Vol. 100 No. 1 (2015): January, 2015 https://doi.org/10.3324/haematol.2014.112037